Le Lézard
Classified in: Health
Subjects: NPT, EXE, REL, AVO

FRC Applauds DOJ Guidance Protecting Religious Freedom, Exempting from Oppressive HHS Mandate



WASHINGTON, Oct. 6, 2017 /PRNewswire-USNewswire/ -- Family Research Council applauded two major actions today by the Trump administration that safeguard religious freedom.   The Department of Justice (DOJ) is directing federal agencies to respect religious freedom while the Department of Health and Human Services (HHS) is exempting religious entities from the oppressive Obama contraceptive mandate.

Family Research Council logo (PRNewsFoto/Family Research Council)

Family Research Council President Tony Perkins released the following statement:

"After eight years of the federal government's relentless assault on the First Amendment, the Trump administration has taken concrete steps today that will once again erect a bulwark of protection around American's First Freedom ? religious freedom.  

"President Trump is demonstrating his commitment to undoing the anti-faith policies of the previous administration and restoring true religious freedom.    Last May, the president ordered the federal government to vigorously promote and protect religious liberty ?and now the DOJ and HHS are moving to make that order a reality.  

"Under the Obama administration, agencies lost the understanding that religious freedoms extend to the public square, not just one's place of worship.   As a result, our own government began threatening hardworking, patriotic Americans with crushing fines for simply seeking to live their lives according to their faith.    

"President Trump and the Department of Justice are putting federal government agencies on notice: you will not only respect the freedom of every American to believe but live according to those beliefs.  This is a freedom that has been a fundamental part of our society since the beginning of our nation.

 "To aid the Trump administration's efforts in vigorously promoting and protecting religious liberty, Family Research Council today is launching a web hotline for those who believe that they have suffered discrimination at the hands of federal agencies based on their religious beliefs or practices. The 'Free to Believe' hotline will help ensure that no federal employee, contractor or citizen will be forced to choose between their faith and equal treatment by the federal government.

"As President Trump continues to follow through on his promises on these core issues, he will continue to have the support of social conservatives on his policy initiatives," concluded Perkins.

Click here for more information on the religious hotline:

http://freetobelieve.com/federal 

SOURCE Family Research Council


These press releases may also interest you

at 02:00
Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151, President and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") announced today that the results of the Global Phase 3 study (MAVORIC: Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) investigating the use of...

at 02:00
Interim data provides important real world insights into the treatment pathway of patients in the UK with chronic myeloid leukaemia    In patients with a suboptimal response in first line; higher rates of subsequent ELN optimal response were...

at 01:30
Capio is strengthening its involvement in the development of digital healthcare solutions by investing MSEK 49 in the new share issue of MSEK 100 that was announced by the e-health provider Doctrin today. By investing, Capio is participating in the...

at 01:23
Nordic Nanovector ASA (OSE: NANO) has presented updated results from its LYMRIT 37-01 Phase 1/2 clinical study of Betalutin® (177Lu-satetraxetan-lilotomab) in patients with relapsed/refractory (R/R) indolent NHL (iNHL) at the 59th Annual ASH meeting...

10 déc 2017
Blessed Herbs Cafe and Mount Zion Rastafarian Church founder and practicing Rasta George Metropoulos today announced the launch of the organization's first holiday season food and cash drive. Directly benefiting the neighborhood's less fortunate...

10 déc 2017
A new article published today in The New England Journal of Medicine shows that 42 percent of diffuse large B cell lymphoma patients treated with axicabtagene ciloleucel, offered commercially under the brand name Yescartatm, remain in remission 15...




News published on 6 october 2017 at 12:23 and distributed by: